Work programme 2015
Introduction
The EMCDDA’s 2015 annual work programme sets out the objectives for the final year of the agency’s 2013–15 strategy. Among the core principles are: delivering a relevant, timely and responsive analysis of the drug situation; achieving efficiency and ensuring that maximum value is delivered from activities and investments; and enhancing communication and a customer-focused approach. This work programme promises also to build a solid bridge between current priorities and those defined for the upcoming strategy (2016–18).
Download as PDF
Table of contents
- Introduction and summary of key outputs
- Main areas of work in 2015
- Monitoring and reporting on the drugs problem in Europe
- Data collection, analysis and quality assurance
- Monitoring and understanding drug use and problems: key indicators and epidemiology
- Monitoring demand reduction responses applied to drug-related problems
- Monitoring drug supply and supply reduction interventions
- Monitoring new trends and developments and assessing the risks of new substances
- Improving Europe’s capacity to monitor and evaluate policies
- Scientific coordination, research and content support
- Cooperation and collaboration with key partners
- Supporting the achievement of results
- Communicating the EMCDDA’s findings to external audiences
- Governance, management and networks
- Support to operations
- Administration: supporting core business
- Information and communication technology (ICT)
- Annexes
- Potential risk factors
- Estimated budget allocation
- Key performance indicators
- List of procurements
- List of beneficiaries of Reitox grants
- Template of the 2015 Reitox grant
- List of abbreviations and acronyms